CD4+ T cell-mediated immunity against prion proteins

被引:10
|
作者
Stoltze, L
Rezaei, H
Jung, G
Grosclaude, J
Debey, P
Schild, H
Rammensee, HG
机构
[1] Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany
[2] Museum Natl Hist Nat, Unite 806, EA2703, INRA, F-75005 Paris, France
[3] INRA, Unite Virol & Immunol Mol, F-78352 Jouy En Josas, France
[4] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany
关键词
T lymphocyte; prion protein; MHC class II;
D O I
10.1007/s000180300054
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The prion protein (PrPC) is essential for susceptibility to transmissible spongiform encephalopathies. A specific conformer of this protein (PrPSC) is, according to the 'protein only' hypothesis, the principal or only component of the infectious agent, designated prion. Transmission' of prions between species is often inefficient, resulting in low attack rates and/or prolonged incubation times and is ascribed to a 'species barrier' caused by differences in the amino acid sequence of PrP between recipient and donor. In this report, we demonstrate that these differences in amino acid sequence result in presentation of distinct peptides on major histocompatibility complex class II molecules. These peptides result in activation of specific CD4(+) T cells which leads to the induction of an effective immune response against foreign PrP as demonstrated by antibody production. Therefore, CD4(+) T cells represent a crucial component of the immune system to distinguish between foreign and self PrP.
引用
收藏
页码:629 / 638
页数:10
相关论文
共 50 条
  • [1] CD4+ T cell-mediated immunity against prion proteins
    L. Stoltze
    H. Rezaei
    G. Jung
    J. Grosclaude
    P. Debey
    H. Schild
    H.-G. Rammensee
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 629 - 638
  • [2] CD4+ T Cell-Mediated Immunity against the Phagosomal Pathogen Leishmania: Implications for Vaccination
    Hohman, Leah S.
    Peters, Nathan C.
    TRENDS IN PARASITOLOGY, 2019, 35 (06) : 423 - 435
  • [3] Deciphering CD4+ T cell-mediated responses against cancer
    Kirkpatrick, Catherine
    Lu, Yong-Chen William
    MOLECULAR CARCINOGENESIS, 2024, 63 (07) : 1209 - 1220
  • [4] Neddylation contributes to CD4+ T cell-mediated protective immunity against blood-stage Plasmodium infection
    Cheng, Qianqian
    Liu, Jian
    Pei, Yujun
    Zhang, Yaolin
    Zhou, Dawang
    Pan, Weiqing
    Zhang, Jiyan
    PLOS PATHOGENS, 2018, 14 (11)
  • [5] CMV cell-mediated immunity assays: Focus on CD4+ cells
    Lerner, Alexis H.
    Farmakiotis, Dimitrios
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (08) : 2285 - 2286
  • [6] A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity
    Pino-Lagos, Karina
    Guo, Yanxia
    Brown, Chrysothemis
    Alexander, Matthew P.
    Elgueta, Raul
    Bennett, Kathryn A.
    De Vries, Victor
    Nowak, Elizabeth
    Blomhoff, Rune
    Sockanathan, Shanthini
    Chandraratna, Roshantha A.
    Dmitrovsky, Ethan
    Noelle, Randolph J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (09): : 1767 - 1775
  • [7] CD8+ and CD4+ T cell-mediated immunity against novel EphA2-derived epitopes in patients with renal cell carcinoma
    Herrem, CJ
    Tatsumi, T
    Olson, W
    Finke, JH
    Bukowski, RM
    Kinch, MS
    Storkus, WJ
    FASEB JOURNAL, 2003, 17 (07): : C333 - C333
  • [8] A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins
    Haque, Ashraful
    Chu, Karen
    Easton, Anna
    Stevens, Mark P.
    Galyov, Edouard E.
    Atkins, Tim
    Titball, Rick
    Bancroft, Gregory J.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (09): : 1241 - 1248
  • [9] GILT: shaping the MHC class II-restricted peptidome and CD4+ T cell-mediated immunity
    Hastings, Karen Taraszka
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [10] IL-12-assisted immunization generates CD4+ T cell-mediated immunity to Listeria monocytogenes
    Miller, MA
    Skeen, MJ
    Lavine, CL
    Ziegler, HK
    CELLULAR IMMUNOLOGY, 2003, 222 (01) : 1 - 14